| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 4.927 | 34.751 | 65.133 | 100.584 | 156.566 | 181.861 | 239.486 |
| Total Income - EUR | - | - | 0 | 4.927 | 34.842 | 65.136 | 101.078 | 158.141 | 182.970 | 240.090 |
| Total Expenses - EUR | - | - | 119 | 5.740 | 22.968 | 40.424 | 60.394 | 110.128 | 120.809 | 144.176 |
| Gross Profit/Loss - EUR | - | - | -119 | -813 | 11.874 | 24.712 | 40.684 | 48.013 | 62.160 | 95.914 |
| Net Profit/Loss - EUR | - | - | -119 | -860 | 11.286 | 24.262 | 39.812 | 46.674 | 60.610 | 89.807 |
| Employees | - | - | 0 | 1 | 1 | 2 | 2 | 3 | 3 | 3 |
Check the financial reports for the company - Chirodermatologie S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 782 | 664 | 2.003 | 40.603 | 110.517 | 112.879 | 345.197 |
| Current Assets | - | - | 2 | 749 | 13.028 | 24.681 | 18.914 | 15.672 | 37.855 | 42.880 |
| Inventories | - | - | 0 | 0 | 403 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 0 | 2.373 | 773 | 2.323 | 3.827 | 8.046 | 4.604 |
| Cash | - | - | 2 | 749 | 10.252 | 23.908 | 16.591 | 11.845 | 29.809 | 38.276 |
| Shareholders Funds | - | - | -75 | -934 | 10.370 | 24.311 | 55.073 | 96.582 | 144.373 | 233.373 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 77 | 2.464 | 3.322 | 2.523 | 2.112 | 27.841 | 5.184 | 154.116 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 2.426 | 1.825 | 1.213 | 603 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Chirodermatologie S.r.l.